Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermatophyte fungi are a specialized group of filamentous fungi, primarily encompassing the genera Trichophyton, Microsporum, and Epidermophyton, which possess the unique ability to invade and thrive in keratinized tissues such as the skin, hair, and nails (StatPearls, 2023). These organisms secrete keratinolytic enzymes that break down structural proteins for nutrition, leading to clinical infections collectively termed dermatophytosis or tinea (Journal of Fungi, 2021). While the fungi represent the infectious agent, therapeutic interventions target specific molecular pathways within the fungal cell, most notably the ergosterol biosynthesis pathway (Nature Reviews Disease Primers, 2020). Drugs like allylamines (e.g., terbinafine) inhibit squalene epoxidase, while azoles (e.g., itraconazole) target lanosterol 14-alpha-demethylase, both resulting in membrane instability and fungal death (Clinical Microbiology Reviews, 2017). Other agents, such as griseofulvin, interfere with microtubule assembly to inhibit fungal mitosis (NIH, 2023). Understanding these organisms is critical for managing widespread conditions like athlete's foot and onychomycosis, especially given the rising challenge of antifungal resistance in certain species (CDC, 2022). Safety concerns for systemic treatments include potential hepatotoxicity and significant drug-drug interactions due to the inhibition of human cytochrome P450 enzymes (PubMed, 2022). Diagnosis typically involves microscopic examination of skin scrapings or fungal culture to identify the specific causative agent (StatPearls, 2023).
Inhibition of squalene epoxidase, inhibition of lanosterol 14-alpha-demethylase, and disruption of microtubule assembly.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermatophyte fungi.